Pharmaceutical preparations for treatment of autoimmune diseases; pharmaceutical preparations for treatment of inflammatory diseases; pharmaceutical preparations for treatment of cancer; pharmaceutical preparations for treatment of rheumatoid arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, psoriatic arthritis, Crohn's disease, paediatric Crohn's disease, ulcerative colitis, psoriasis, paediatric plaque psoriasis, uveitis, hidradenitis suppurativa, asthma, bronchitis, CODP, ...

Pharmaceutical preparations for treatment of diseases caused by IL-6 (interleukin-6) production, namely, pharmaceutical preparations for treatment of rheumatoid arthritis; Pharmaceutical preparations comprising an anti-IL-6 (interleukin-6) receptor monoclonal antibody, namely, pharmaceutical preparations for treatment of rheumatoid arthritis and pharmaceutical preparations for prevention of rheumatoid arthritis